The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.

You can also contact the CTN coordinating centre for additional information:

Study Name on (link is external)
A Study to Assess the Effect of ELX/TEZ/IVA on Glucose Tolerance in Participants With Cystic Fibrosis
Study Drug Elexacaftor/Tezacaftor/Ivacaftor 
Type of Study Drug CFTR modulation
Study Title A Phase 3b Open-Label Study to Assess the Effect of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance in Cystic Fibrosis Subjects With Abnormal Glucose Metabolism
Study Phase 3b
Study Sponsor Vertex

Link on (link is external) 

Participating ECFS-CTN sites Please contact for most recent sitelist
Age Subjects Ages 12 Years and Older